Novanta (NASDAQ: NOVT) CEO sells 6,500 shares in planned trades
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Novanta Inc. Chief Executive Officer Matthijs Glastra reported open-market sales of 6,500 shares of Novanta common stock. The transactions occurred on July 2, 2026 across five trades at reported prices between $160.13 and $164.20 per share, classified as open-market sales.
The filing states these sales were effected under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025 through a trust for which his spouse is a trustee. Following the transactions, Glastra holds 29,761 shares directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust.
Positive
- None.
Negative
- None.
Insights
CEO executes pre-planned sale of 6,500 Novanta shares, retains sizable stake.
Novanta’s Chief Executive Officer, Matthijs Glastra, reported selling 6,500 shares of common stock in five open-market transactions on July 2, 2026. Sale prices ranged from about $160.13 to $164.20 per share, with all trades coded as open-market sales.
The filing states these sales were made under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025 through a trust where his spouse serves as trustee, indicating the timing was pre-arranged rather than discretionary. After the transactions, Glastra continues to hold 29,761 shares directly and 54,382 shares indirectly via the 2021 irrevocable trust, suggesting the sales represent only a portion of his overall reported holdings.
Insider Trade Summary 10b5-1
Net Seller: 6,500 shares ($1,047,340)
Net Sell
6 txns
Insider
Glastra Matthijs
Role
Chief Executive Officer
Sold
6,500 shs ($1.05M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,024 | $160.13 | $484K |
| Sale | Common Stock | 1,672 | $161.28 | $270K |
| Sale | Common Stock | 1,167 | $162.01 | $189K |
| Sale | Common Stock | 437 | $163.71 | $72K |
| Sale | Common Stock | 200 | $164.20 | $33K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 33,237 shares (Direct, null);
Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee. This transaction was executed in multiple trades ranging from $159.72 to $160.66. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $160.74 to $161.74. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $161.83 to $162.76. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $163.09 to $163.95. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 6,500 shares
Sale price tranche: $164.20 per share
Sale price tranche: $160.13 per share
+3 more
6 metrics
Shares sold
6,500 shares
Total Novanta common shares sold on July 2, 2026
Sale price tranche
$164.20 per share
Highest reported weighted-average sale price on July 2, 2026
Sale price tranche
$160.13 per share
Lowest reported weighted-average sale price on July 2, 2026
Direct holdings after sale
29,761 shares
Common stock held directly by CEO after transactions
Indirect holdings
54,382 shares
Common stock held via Matthijs Glastra 2021 Irrevocable Trust
Rule 10b5-1 plan adoption date
September 11, 2025
Date the pre-established trading plan was adopted
Key Terms
Rule 10b5-1 trading plan, weighted-average price, irrevocable trust, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported above reflects the weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
irrevocable trust financial
"nature_of_ownership: Matthijs Glastra 2021 Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did Novanta (NOVT) CEO Matthijs Glastra report in this Form 4?
He reported selling 6,500 shares of Novanta common stock in open-market transactions. The trades occurred on July 2, 2026 and were executed in five tranches at reported prices between $160.13 and $164.20 per share, according to the Form 4 details.